Overview

Epilepsia Open was founded in 2016 as the official Open Access journal of the International League Against Epilepsy (ILAE). 

Aims and Scope

The primary aim of Epilepsia Open is to rapidly publish robust high quality results that provide insights in all aspects of epilepsy research. Specifically, Epilepsia Open will publish peer reviewed, high quality open access articles covering the entire breadth of basic, translational and clinical research in epilepsy. The spectrum of articles may include all disciplines of life and health sciences, such as public/global health science and societal impact studies. Epilepsia Open also welcomes submissions of high quality research with confirmatory results, failure-to-confirm studies, and negative results or interesting study protocols for testing new treatments. Epilepsia Open will publish communications from the ILAE and its Chapters. A priority is also given to commentaries of issues and concepts that enhance the access and application of basic research findings for clinical scientists and health professionals, and promote a better understanding of clinical challenges for biomedical researchers. Epilepsia Open is creating a unique forum for the reputable and speedy open access publication of epilepsy research. We are committed to facilitating and invigorating a robust and successful pipeline for improved human health science in epilepsy.

 

Abstracting and Indexing Information

  • Current Contents: Clinical Medicine (Clarivate Analytics)
  • Current Contents: Life Sciences (Clarivate Analytics)
  • Directory of Open Access Journals (DOAJ)
  • Embase (Elsevier)
  • MEDLINE/PubMed (NLM)
  • PubMed (NLM) 
  • Science Citation Index Expanded (Clarivate Analytics)
  • SCOPUS (Elsevier)
  • Web of Science (Clarivate Analytics)
Epilepsia Open deposits all articles in PMC (PubMed Central)

Epilepsia Open received its first impact factor in 2022. The 2021 Impact Factor for Epilepsia Open is 4.026, ranking 90/212 in Clinical Neurology (Q2).